None listed
Conditions
Interventions
Others(Autologous fat mechanical stromal vascular fraction (mSVF) separated by micropore method including autologous platelet-rich plasma) : Separate mSVF from autologous fat and directly inject appro
Sponsors
Sinsoe Women's Clinic
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Women aged 20 to 40 years with a need for childbirth 2. Patients diagnosed with premature ovarian failure with a serum level of follicle-stimulating hormone (FSH) of 25 mlU/mL or higher 3. Patients with a serum level of anti-Müllerian hormone (AMH) of 1.1 ng/mL or lower 4. Menstrual cessation or menorrhagia for at least 4 months 5. Women with a uterus and bilateral adnexa 6. Those who voluntarily participated in the study after receiving a sufficient explanation of the study
Exclusion criteria
Exclusion criteria: 1. Women with autoimmune diseases 2. Women with severe diseases that make pregnancy unsuitable, such as diseases of the circulatory, urinary, digestive, endocrine, respiratory, or immune systems 3. Women who have continuously used systemic glucocorticoids or other immunosuppressants for more than 3 weeks within 6 months 4. Women with a history of malignancy, radiotherapy, or chemotherapy 5. Those who are confirmed to be pregnant or breastfeeding 6. Those registered in other clinical studies and trials 7. Those deemed unsuitable by other investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse Events | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood hormone test (AMH, FSH, LH, E2);Bone Mineral Density (BMD) | — |
Countries
Korea, Republic of
Contacts
Public ContactJAE YOUNG CHO
Sinsoe Women's Clinic
Outcome results
None listed